Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance

Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance

Anna S Griffith,1 Paul H Hayashi,1 Lauren MB Burke,2 Autumn J McRee1 1Department of Medicine, 2Department of Radiology, University of North Carolina at Chapel Hill Hospital, Chapel Hill, NC, USA Abstract: We describe two cases of patients with hepatitis C virus (HCV) treated with direct-acting antiv...

Full description

Bibliographic Details
Main Authors:	Griffith AS, Hayashi PH, Burke LMB, McRee AJ
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-05-01
Series:	Journal of Hepatocellular Carcinoma
Subjects:	Hepatocellular Carcinoma Hepatitis C Virus Sustained Virologic Response Direct Acting Antiviral T-cell mediated immunosurveillance
Online Access:	https://www.dovepress.com/decreased-hepatocellular-carcinoma-tumor-burden-with-the-achievement-o-peer-reviewed-article-JHC

Similar Items

Hepatocellular Senescence: Immunosurveillance and Future Senescence-Induced Therapy in Hepatocellular Carcinoma
by: Peng Liu, et al.
Published: (2020-11-01)

Immunosurveillance of cancer cell stress
by: Seila Lorenzo-Herrero, et al.
Published: (2019-07-01)

Risk of Hepatocellular Carcinoma after HCV Clearance by Direct-Acting Antivirals Treatment Predictive Factors and Role of Epigenetics
by: Luca Rinaldi, et al.
Published: (2020-05-01)

Pro-necrotic molecules impact local immunosurveillance in human breast cancer
by: Gautier Stoll, et al.
Published: (2017-04-01)

Harnessing immunosurveillance: current developments and future directions in cancer immunotherapy
by: Drakes ML, et al.
Published: (2014-12-01)

Immunosurveillance and immunoediting in MMTV-PyMT-induced mammary oncogenesis
by: Emilie T. E. Gross, et al.
Published: (2017-02-01)

Molecular Mechanisms of Hepatocarcinogenesis Following Sustained Virological Response in Patients with Chronic Hepatitis C Virus Infection
by: C. Nelson Hayes, et al.
Published: (2018-09-01)

KIR+ CD8+ T Lymphocytes in Cancer Immunosurveillance and Patient Survival: Gene Expression Profiling
by: Lourdes Gimeno, et al.
Published: (2020-10-01)

Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis
by: Nelson Cheinquer, et al.

Immunosurveillance of Cancer and Viral Infections with Regard to Alterations of Human NK Cells Originating from Lifestyle and Aging
by: Xuewen Deng, et al.
Published: (2021-05-01)

Ombitasvir, paritaprevir, and ritonavir with peginterferon-α2a plus ribavirin in treatment-experienced patients with chronic hepatitis C virus genotype 1 infection
by: Bernstein D, et al.
Published: (2019-02-01)

Lactate dehydrogenase-elevating virus enhances natural killer cell-mediated immunosurveillance of mouse mesothelioma development
by: Mohamed F. Mandour, et al.
Published: (2020-05-01)

Long-Term Follow-Up of Advanced Liver Disease after Sustained Virological Response to Treatment of Hepatitis C with Direct-Acting Antivirals: Outcomes from a Real-World Portuguese Cohort
by: Tiago Pereira Guedes, et al.
Published: (2019-10-01)

Concordance of sustained virologic response at weeks 4, 12 and 24 post-treatment of hepatitis C in the era of new oral direct-acting antivirals: A concise review
by: Sarah V. Burgess, et al.
Published: (2016-03-01)

The Oncoprotein SKI Acts as A Suppressor of NK Cell-Mediated Immunosurveillance in PDAC
by: Viviane Ponath, et al.
Published: (2020-10-01)

The impact of achieving a sustained virological response with direct-acting antivirals on serum autotaxin levels in chronic hepatitis C patients
by: Shereen Abou Bakr Saleh, et al.
Published: (2020-11-01)

Predictors Associated with Increase in Skeletal Muscle Mass after Sustained Virological Response in Chronic Hepatitis C Treated with Direct Acting Antivirals
by: Kazunori Yoh, et al.
Published: (2017-10-01)

Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infection
by: Cody Orr, et al.
Published: (2020-12-01)

Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with Antivirals
by: Tatsuya Minami, et al.
Published: (2021-06-01)

Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C
by: Seong Kyun Na, et al.
Published: (2019-09-01)

Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals
by: Hye Won Lee, et al.
Published: (2020-11-01)

Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma recurrence
by: Nevine Ibrahim Musa, et al.
Published: (2020-07-01)

Impact of Sustained Virological Response for Gastroesophageal Varices in Hepatitis-C-Virus-Related Liver Cirrhosis
by: Yukihisa Yuri, et al.
Published: (2019-12-01)

Immunological Mechanisms for Hepatocellular Carcinoma Risk after Direct-Acting Antiviral Treatment of Hepatitis C Virus Infection
by: Pil Soo Sung, et al.
Published: (2021-01-01)

1st Workshop of the Canadian Society for Virology
by: Craig McCormick, et al.
Published: (2017-03-01)

31st Brazilian Online Society for Virology (SBV) 2020 Annual Meeting
by: Luciana Barros de Arruda, et al.
Published: (2021-03-01)

Research advances in risk factors for hepatocellular carcinoma in chronic hepatitis C patients with sustained virologic response
by: YANG Luxuan, et al.
Published: (2017-03-01)

Incidence of Hepatocellular Carcinoma after Treatment with Sofosbuvir-Based or Sofosbuvir-Free Regimens in Patients with Chronic Hepatitis C
by: Eiichi Ogawa, et al.
Published: (2020-09-01)

Impact of antiviral therapy on hepatocellular carcinoma and mortality in patients with chronic hepatitis C: systematic review and meta-analysis
by: Chang Seok Bang, et al.
Published: (2017-04-01)

Molecular Mechanisms Involved in HCC Recurrence after Direct-Acting Antiviral Therapy
by: Rosanna Villani, et al.
Published: (2018-12-01)

Rates of Hepatocellular Carcinoma After Start of Treatment for Chronic Hepatitis C Remain High with Direct Acting Antivirals: Analysis from a Swiss Liver Transplant Center
by: Karbeyaz F, et al.
Published: (2021-06-01)

Post‐treatment serum Wisteria floribunda agglutinin‐positive mac‐2‐binding protein level is a useful predictor of hepatocellular carcinoma development after hepatitis C virus eradication
by: Shunsuke Sato, et al.
Published: (2021-10-01)

Epidemiology and Elimination of HCV-Related Liver Disease
by: Pierre Pradat, et al.
Published: (2018-10-01)

Eradication of hepatitis C virus infection disclosing a previously hidden, underlying autoimmune hepatitis: Autoimmune hepatitis and HCV
by: Valentina Cacciato, et al.
Published: (2020-03-01)

Interferon-Free Regimen: Equally Effective in Treatment Naive and Experienced HCV Patients
by: Crina Fofiu, et al.
Published: (2019-01-01)

Hepatitis C Antiviral Therapy In Patients With Successfully Treated Hepatocellular Carcinoma: Dancing With Wolves
by: El Kassas M, et al.
Published: (2019-11-01)

Effective Immunosurveillance After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia
by: Kunadt D, et al.
Published: (2021-09-01)

Étude du profil cytokinique de patients atteints d’hydatidose : une possible application en matière d’immunosurveillance
by: Mezioug D., et al.
Published: (2009-03-01)

HEPATOCELLULAR CARCINOMA IN A NON-CIRRHOTIC PATIENT WITH SUSTAINED VIROLOGICAL RESPONSE AFTER HEPATITIS C TREATMENT
by: Angelo Alves de MATTOS, et al.
Published: (2015-12-01)

Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancy
by: Ming‐Lun Yeh, et al.
Published: (2021-02-01)